Skip to content
NBDC Human Database

No datasets in the cart.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0197-v7Release info

This page is a past version (v7). The latest version is v31.
Latest version (v31)

Research title

Elucidation of disease state by multi-layered omics analysis

Research overview

Aims
Elucidation of disease biology based on trans-omics analysis, GWAS in the Japanese and trans-ethnic populations
Methods
Metagenome shotgun sequencing, genome-wide association study (GWAS), small RNA-seq and eQTL analyses
Participants/materials
Metagenomic data of gut microbiome in the Japanese population (95 + 103 + 227 + 30 individuals)
Autoimmune pulmonary alveolar proteinosis cases: 198, Control participants: 395
Populations: Biobank Japan (n = 179,000), UK biobank (n = 361,000), ans FinnGen (n = 136,000), Phenotypes: 215
141 Japanese individuals
Metagenomic data of gut microbiome in Inflammatory Bowel Disease (35 Ulcerative Colitis and 39 Crohn's disease) and 40 Healthy controls
URL
N/A

Datasets

The list is the one this version published; each dataset's content is shown as it is now.

CartDataset IDType of dataPlatformsAccess criteriaDate published
JGAD000290Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2020-09-28
NHA000154GWAS for autoimmune pulmonary alveolar proteinosis
  • Illumina Infinium Asian Screening Array
Unrestricted-access2020-11-27
JGAD000363Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2020-11-27
NHA000162GWAS for 215 phenotypes
  • Applied Biosystems UK BiLEVE Axiom Array
  • Applied Biosystems UK Biobank Axiom Array
  • Illumina HumanExome
Unrestricted-access2021-03-22
JGAD000427Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2021-07-31
JGAD000532Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2021-12-10
NHA000164GWAS for 10 phenotypes
  • Illumina HumanExome
  • Illumina HumanOmniExpress
  • Illumina HumanOmniExpressExome
Unrestricted-access2021-12-21
NHA000163Fine-mapping for 79 phenotypes
  • Illumina HumanExome
  • Illumina HumanOmniExpress
  • Illumina HumanOmniExpressExome
Unrestricted-access2021-12-21
JGAD000621Read count data of miRNA
  • Illumina HiSeq 2500
Controlled-access (Type I)2022-02-21
NHA000166eQTL data
  • Illumina HiSeq 2500
  • Illumina HiSeq X
Unrestricted-access2022-02-08
JGAD000649Metagenome
  • Illumina HiSeq 3000
  • Illumina NovaSeq 6000
Controlled-access (Type I)2022-05-20

Data provider

Principal investigator
Yukinori Okada
Affiliation
Department of Statistical Genetics, Osaka University Graduate School of Medicine

Research projects

No research projects.

Grants

NameTitleProject number
Precursory Research for Innovative Medical care (PRIME), Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)
Crosstalk among microbiome, host, disease, and drug discovery enhanced by statistical genetics
  • JP19gm6010001
FORCE, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)
Elucidation of disease-specific microbiota and personalized medicine by metagenome-wide association studies
  • JP20gm4010006
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development (AMED)
Biology and in silico drug repositioning of pulmonary alveolar proteinosis using trans-layer omics analysis
  • JP20ek0109413
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)
Nucleic genome drug discovery for autoimmune diseases through in-silico and patient-oriented screening utilizing large-scale disease genetics
  • JP19ek0410041
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)
Genomic prediction medicine of rheumatoid arthritis based on comprehensive immune-omics resources
  • JP21ek0410075
Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)
Implementation of genomic prediction medicine based on statistical genetics
  • JP21km0405211
Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)
Next-generation genomics analyses elucidates biology, personalized medicine, and drug discovery of psoriasis
  • JP21km0405217
KAKENHI Grant-in-Aid for Scientific Research (A)
Elucidation of disease biology and tissue specificity by trans-layer omics analysis and whole-genome sequencing
  • 19H01021

Related publications

TitleDOIDataset ID
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.
Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology.
A global atlas of genetic associations of 220 deep phenotypes
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease
Insights from complex trait fine-mapping across diverse populations
Genetic architecture of microRNA expression and its link to complex diseases in the Japanese population.

Controlled access users

Principal investigatorAffiliationCountry/RegionResearch titlePeriod of data useDataset ID
Ilana BritoMeinig School of Biomedical Engineering, Cornell UniversityNew York, United StatesComparative metagenomics of lupus patients' microbiomes (Protocol Number IRB0144130)2022-05-12 – 2025-01-08
Yongxin LIThe department of Chemistry, The University of Hong KongChinaComparison of gut bacterial diversity and composition in MS/EAE2022-09-26 – 2025-06-09
Michiaki HamadaHamada Laboratory, Faculty of Science and Engineering, Waseda UniversityJapanConstruction of RNA-targeted Drug Discovery Database2023-01-05 – 2027-10-31
Tina FuchsInstitute for Clinical Chemistry, Medical Faculty Mannheim, Heidelberg UniversityGermanyInvestigating the clonality of VIREM cells in COVID-19 patients2024-02-26 – 2025-04-14
Koichi MatsudaClinical genome sequencing, The University of TokyoJapanDisease Cohort Research Network for Disease Marker Exploratory Studies2024-06-17 – 2029-03-31
Yuhei KiritaDepartment of Nephrology, Kyoto Prefectural University of MedicineJapanElucidation of the Pathogenesis through Comparative Analysis of Peripheral Blood Gene Expression in IgA Nephropathy and Immune-related Diseases2025-07-29 – 2030-03-31